These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 19110302)

  • 1. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
    Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
    Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
    Hainsworth JD; Spigel DR; Litchy S; Greco FA
    J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
    Hoskins PJ; Swenerton KD; Pike JA; Lim P; Aquino-Parsons C; Wong F; Lee N
    J Clin Oncol; 2003 Sep; 21(18):3495-501. PubMed ID: 12972526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
    Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA
    Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
    Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
    Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
    Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N
    Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
    Kastritis E; Bamias A; Bozas G; Koutsoukou V; Voulgaris Z; Vlahos G; Rodolakis A; Gika D; Papadimitriou C; Dimopoulos MA
    Gynecol Oncol; 2007 Feb; 104(2):372-6. PubMed ID: 17030353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.